Association of Behçet's disease with the risk of metabolic syndrome and its components: a systematic review and meta-analysis
- PMID: 36939969
- PMCID: PMC10543763
- DOI: 10.1007/s10238-023-01044-x
Association of Behçet's disease with the risk of metabolic syndrome and its components: a systematic review and meta-analysis
Abstract
The present meta-analysis aimed to elucidate the association of Behçet's disease (BD) with the risk of metabolic syndrome (MetS) and its components. Observational cohort studies were searched from the Embase, Web of Science, Medline, and Cochrane Library databases. The primary outcome was the association of BD with the risk of MetS and its relevant components. Effect estimates with odds ratios (ORs) were pooled using either the random-effects or fixed-effects models, according to heterogeneity. Leave-one-out sensitivity analyses were used to determine the stability of the results. Twenty-three studies, comprising 42,834 patients with BD, were included. Overall, a significant association between BD and the risk of MetS was found (pooled OR 2.26; 95% confidence interval [CI] 1.61-3.17; P < 0.0001). Among the components of MetS, significant associations were found between BD and diabetes mellitus (OR 1.21; 95% CI 1.10-1.33; P < 0.0001), BD and hypertension (OR 1.39; 95% CI 1.13-1.70; P = 0.002), and BD and dyslipidemia (OR 1.21; 95% CI 1.01-1.45; P = 0.04). Our study indicated an association between BD and the risk of MetS and some of its components (diabetes mellitus, hypertension, and dyslipidemia). Physician should consider these associations so that specific treatments are available for patients with comorbidities. Moreover, patients with BD should regularly monitor their blood pressure, fasting plasma glucose, and blood lipid levels.
Keywords: Behçet’s disease; Diabetes mellitus; Dyslipidemia; Hypertension; Meta-analysis; Metabolic syndrome.
© 2023. The Author(s).
Conflict of interest statement
The authors report no potential conflict of interest.
Figures






Similar articles
-
Association between metabolic syndrome and Behçet's disease: A nationwide population-based study.J Dermatol. 2021 Jul;48(7):1062-1066. doi: 10.1111/1346-8138.15809. Epub 2021 May 7. J Dermatol. 2021. PMID: 33961305
-
Association of Interleukin-23R Gene Polymorphisms with Behcet's Disease Susceptibility: A Meta-Analysis of Case-control Studies.Immunol Invest. 2020 Aug;49(6):648-661. doi: 10.1080/08820139.2019.1698600. Epub 2019 Dec 9. Immunol Invest. 2020. PMID: 31814470
-
Association between vitiligo and relevant components of metabolic syndrome: a systematic review and meta-analysis.J Dtsch Dermatol Ges. 2022 May;20(5):629-641. doi: 10.1111/ddg.14717. Epub 2022 May 2. J Dtsch Dermatol Ges. 2022. PMID: 35499212
-
Association between metabolic syndrome components and the risk of developing nephrolithiasis: A systematic review and bayesian meta-analysis.F1000Res. 2021 Feb 11;10:104. doi: 10.12688/f1000research.28346.1. eCollection 2021. F1000Res. 2021. PMID: 34804491 Free PMC article.
-
Effect of vegetarian diets on the presentation of metabolic syndrome or its components: A systematic review and meta-analysis.Clin Nutr. 2019 Jun;38(3):1117-1132. doi: 10.1016/j.clnu.2018.05.021. Epub 2018 Jun 6. Clin Nutr. 2019. PMID: 29907356
Cited by
-
Postoperative complications in patients with Behçet's disease.Clin Rheumatol. 2024 Dec;43(12):3829-3838. doi: 10.1007/s10067-024-07212-y. Epub 2024 Oct 29. Clin Rheumatol. 2024. PMID: 39472410 Free PMC article.
-
Epidemiology and treatment of Adamantiades-Behçet's disease in Germany: A healthcare claims database study.J Eur Acad Dermatol Venereol. 2025 May;39(5):1017-1027. doi: 10.1111/jdv.20489. Epub 2024 Dec 12. J Eur Acad Dermatol Venereol. 2025. PMID: 39666543 Free PMC article.
-
Metabolic syndrome and dermatological diseases: association and treatment.Nutr Metab (Lond). 2025 May 6;22(1):36. doi: 10.1186/s12986-025-00924-1. Nutr Metab (Lond). 2025. PMID: 40329305 Free PMC article. Review.
-
Abnormal glucose and lipid metabolism promotes disrupted differentiation of T and B cell subsets in Behçet's disease.Immunother Adv. 2025 Mar 24;5(1):ltaf010. doi: 10.1093/immadv/ltaf010. eCollection 2025. Immunother Adv. 2025. PMID: 40297266 Free PMC article.
-
Obesity, body fat distribution and eye diseases.Eat Weight Disord. 2024 May 6;29(1):33. doi: 10.1007/s40519-024-01662-8. Eat Weight Disord. 2024. PMID: 38710948 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical